Rare
lephants
Screener
Toggle theme
Insulet Corp.
PODD
·
Healthcare, Medical Devices, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2022
FY2020
FY2019
FY2018
FY2017
FY2016
FY2014
FY2013
Total Cash from Operations:
$350.3M
Line Item
Value
% of Total
Capital Expenditures
$16.2M
4.6%
Other Investing
$30.2M
8.6%
Working Capital
$4.5M
1.3%
Other
$164.0M
46.8%
Net Cash Flow
$135.4M
38.7%
Download CSV
